XClose

Positive Behaviour Support

Home
Menu

Michaela's Biography

Michaela Poppe
Michaela studied Patholinguistics at the University of Potsdam in Germany and completed an MSc in Human Communication at UCL. She went on to do a PhD in Psychology at King's College London investigating language function in mild cognitive impairment and Alzheimer's disease. Michaela worked on several clinical trials and qualitative studies in the field of dementia at the Institute of Psychiatry at King's College London.

 

 

Selected Publications:

  • Poppe, M.; Burleigh, S.; Banerjee, S. Qualitative Evaluation of Advanced Care Planning in Early Dementia (ACP-ED). PLoS ONE, 2013, 8(4): e60412. doi:10.1371/journal.pone.0060412
  • Banerjee, S.; Hellier, J.; Dewey, M.; Romeo, R.; Ballard, C.; Baldwin, R.; Bentham, P.; Fox, C.; Holmes, C.; Katona, C.; Knapp, M.; Lawton, C.; Lindesay, J.; Livingston, G.; McCrae, N.; Moniz-Cook, E.; Murray, J.; Nurock, S.; Orrell, M.; O’Brien, J.; Poppe, M.; Thomas, A.; Walwyn, R.; Wilson, K.; Burns, A. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet, 2011, 378, 403-411.
  • Velayudhan, L.; Poppe, M.; Archer, N.; Proitsi, P.; Brown, R.G.; Lovestone, S. Risk of developing dementia in people with diabetes and mild cognitive impairment. British Journal of Psychiatry, 2010, 196, 36-40.
  • Macdonald, A.; Briggs, K.; Poppe, M.; Higgins, A; Velayudhan, L.; Lovestone, S. A feasibility and tolerability study of lithium in Alzheimer’s disease. International Journal of Geriatric Psychiatry, 2008, 23, 704-711.